U., M., E., F., M., S., D., C., H., G., M.K., J., . . . V., S. (2023). Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy.
Citación estilo ChicagoU., Moore, et al. Myostatin and Follistatin As Monitoring and Prognostic Biomarkers in Dysferlinopathy. 2023.
Cita MLAU., Moore, et al. Myostatin and Follistatin As Monitoring and Prognostic Biomarkers in Dysferlinopathy. 2023.
Precaución: Estas citas no son 100% exactas.